Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.

< BACK TO ARCHIVE


2022 Oct 29


Ann Pharmacother


http://www.ncbi.nlm.nih.gov/pubmed/36314271?dopt=Abstract

Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.

Authors

Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
Habeeb EA, Tran LK, Goodberlet MZ, Lupi KE, DeGrado JR, Dube KM
Ann Pharmacother. 2022 Oct 29:10600280221132851.
PMID: 36314271.

Abstract

Opioid-induced constipation (OIC) may occur in up to 81% of critically ill patients and can lead to many complications. Opioid antagonists are a reasonable approach and may be used for managing OIC.
Read This Paper